Hexachlorocyclopentadiene
SmallMolecule
T3DB_ID
T3D0165
描述
Hexachlorocyclopentadiene (HCCPD) is a light, lemon-yellow liquid that has a sharp, musty odor. It easily turns from a liquid to a vapor when exposed to air. The vapor looks like a blue haze. HCCPD is a manufactured chemical and does not occur naturally in the environment. It is made by adding chlorine to cyclopentadiene, or by removing chlorine from octachlorocyclopentane. HCCPD is used to make a group of related pesticides (aldrin, chlordane, dieldrin, endosulfan, endrin, heptachlor, isodrin, mirex, and pentac) referred to cyclodienes. Only two of these pesticides, endosulfan and pentac, are currently registered for use in the United States. (L437)
类别
"Pesticide", "Industrial/Workplace Toxin", "Pollutant", "Airborne Pollutant", "Food Toxin", "Synthetic Toxin"
同义词
"1,2,3,4,5,5-Hexachloro-1,3-cyclopentadiene", "1,2,3,4,5,5-Hexachloro-cyclopenta-1,3-diene", "1,2,3,4,5,5-Hexachlorocyclopenta-1,3-diene", "1,2,3,4,5,5-Hexachlorocyclopentadiene", "Graphlox", "Hexachloro-1,3-cyclopentadiene", "Perchloro-1,3-cyclopentadiene", "Perchlorocyclopentadiene"
CAS登记号
77-47-4
化学式
C5Cl6
平均分子量
272.772
单同位素质量
269.813116242
IUPAC 名称
hexachlorocyclopenta-1,3-diene
传统名称
hexachlorocyclopentadiene
简化分子线性输入规范
ClC1=C(Cl)C(Cl)(Cl)C(Cl)=C1Cl
InChI 标识符
InChI=1S/C5Cl6/c6-1-2(7)4(9)5(10,11)3(1)8
InChIKey=VUNCWTMEJYMOOR-UHFFFAOYSA-N
化合物类型
Organic compounds
大分类
Organohalogen compounds
类型
Vinyl halides
子类
Vinyl chlorides
直接大类
Vinyl chlorides
另外分类
"Alkyl chlorides", "Chloroalkenes", "Hydrocarbon derivatives", "Organochlorides"
取代基
"Aliphatic homomonocyclic compound", "Alkyl chloride", "Alkyl halide", "Chloroalkene", "Haloalkene", "Hydrocarbon derivative", "Organochloride", "Vinyl chloride"
分子框架
Aliphatic homomonocyclic compounds
外部描述符
""
地位
Detected and Not Quantified
起源
Exogenous
蜂窝位置
"Membrane"
生物流体位置
组织位置
途径
状态
Liquid
外貌
熔点/沸点/溶解度
-9°C/239°C/0.0018 mg/mL at 25 °C [CALLAHAN,MA et al. (1979)]
日志P
暴露途径
Inhalation (L442) ; oral (L442) ; dermal (L442) ; eye contact (L442)
毒性机制
HCCPD may interact with the microsomes that binds to secretory molecules and changes their ability to be transported from the cell. It can be postulated, that some of its toxic properties are a consequence of its reactivity in Diels-Alder reactions where a conjugated diene combines with a substituted or unsubstituted alkene (a dienophile) in a cycloaddition reaction. Biological tissues contain a large number of potential reactants for cycloaddition reactions. HCCPD can also undergo addition and substitution reactions or be oxidized by way of the mixed function oxidase system. Effects of HCCPD on the brain may also be a reflection of the reaction of either HCCPD or a metabolite with brain lipids. The effects of HCCPD on the adrenal glands may be a reflection of its ability to combine with the unsaturated carbons in sterols produced by this gland. The hydroxyl functional group of a sterol is on a carbon adjacent to the double bond and can activate that bond to cycloaddition reactions. Such reactions would require exposure to large doses of HCCPD so that reactive material would reach the adrenal gland. HCCPD is excreted in urine and feces. (L437)
代谢
HCCPD is rapidly metabolized and distributed to blood, liver, kidneys, and lungs before being distributed to the peripheral tissues. (L437)
毒性值
LD50: 471 mg/kg (Oral, Rat) (L437)
致死剂量
致癌性
No indication of carcinogenicity to humans (not listed by IARC).
用途/来源
HCCPD is used to make a group of related pesticides (aldrin, chlordane, dieldrin, endosulfan, endrin, heptachlor, isodrin, mirex, and pentac) referred to cyclodienes. Exposure may result from eating contaminated food, drinking contaminated water, and exposing the skin or eye to hexachlorocyclopentadiene. (L437)
最低风险等级
Intermediate Inhalation: 0.01 ppm (Rat) (L437) Chronic Inhalation 0.2 ppb (Rat) (L437) Intermediate Oral: 0.1 mg/kg/day (Rat) (L437)
健康影响
Patients exposed to HCCPD may get a sore throat or have shortness of breath and chest discomfort. Bleeding, swelling, and fluid buildup can occur in the lungs. The linings of the respiratory passages and the lungs are very susceptible to damage from low concentrations of HCCPD following inhalation exposure. Inflammation of the tissues can be followed by necrosis, exfoliation, and hemorrhage. Tissue repair is often fibrous in appearance. Long-term exposure to very low levels of HCCPD can produce granular yellow-brown pigmentation of the epithelium of the nose, trachea, larynx, and lungs. High acute oral doses of HCCPD are associated with liver necrosis and tissue degeneration. The kidneys also appear to be a target tissue for HCCPD toxicity. Degenerative lesions in the tubules can result from small oral doses. (L437)
症状
Inhalation of HCCPD can cause cough, sore throat, headache, diarrhoea, dizziness, nausea, vomiting, and laboured breathing. Ingestion of HCCPD can cause abdominal pain,burning sensation, shock or collapse. Dermal exposure can cause redness, pain and skin burns. Eye exposure can cause redness, pain, blurred vision, and severe deep burns. (L442)
治疗
After oral exposure of HCCPD, gastric lavage is recommended. Following inhalation, move patient to fresh air. Monitor for respiratory distress. If cough or difficulty breathing develops, evaluate for respiratory tract irritation, bronchitis, or pneumonitis. Administer oxygen and assist ventilation as required. Treat bronchospasm with inhaled beta2 agonist and oral or parenteral corticosteroids. Irrigate exposed eyes with copious amounts of room temperature water for at least 15 minutes. If the exposure occurs through dermal contact with the toxin, remove contaminated clothing and wash exposed area thoroughly with soap and water. Treat dermal irritation or burns with standard topical therapy. Patients developing dermal hypersensitivity reactions may require treatment with systemic or topical corticosteroids or antihistamines. (T36)
药库 ID
HMDB_ID
PubChem 化合物 ID
6478
维基百科链接
创建于
2009-03-06 18:58:12 UTC
更新于
2014-12-24 20:21:15 UTC
目标
毒素T3DB ID毒素名称目标名称
T3D0165 Hexachlorocyclopentadiene Estrogen receptor beta
T3D0165 Hexachlorocyclopentadiene Estrogen receptor alpha
T3D0165 Hexachlorocyclopentadiene Sodium/potassium-transporting ATPase subunit beta-3
T3D0165 Hexachlorocyclopentadiene Sodium/potassium-transporting ATPase subunit beta-2
T3D0165 Hexachlorocyclopentadiene Sodium/potassium-transporting ATPase subunit beta-1
T3D0165 Hexachlorocyclopentadiene Sodium/potassium-transporting ATPase subunit alpha-4
T3D0165 Hexachlorocyclopentadiene Sodium/potassium-transporting ATPase subunit alpha-3
T3D0165 Hexachlorocyclopentadiene Sodium/potassium-transporting ATPase subunit alpha-2
T3D0165 Hexachlorocyclopentadiene Sodium/potassium-transporting ATPase subunit alpha-1
T3D0165 Hexachlorocyclopentadiene Sodium/potassium-transporting ATPase subunit gamma
T3D0165 Hexachlorocyclopentadiene Sarcoplasmic/endoplasmic reticulum calcium ATPase 3
T3D0165 Hexachlorocyclopentadiene Sarcoplasmic/endoplasmic reticulum calcium ATPase 2
T3D0165 Hexachlorocyclopentadiene Sarcoplasmic/endoplasmic reticulum calcium ATPase 1
T3D0165 Hexachlorocyclopentadiene Plasma membrane calcium-transporting ATPase 4
T3D0165 Hexachlorocyclopentadiene Plasma membrane calcium-transporting ATPase 3
T3D0165 Hexachlorocyclopentadiene Plasma membrane calcium-transporting ATPase 2
T3D0165 Hexachlorocyclopentadiene Plasma membrane calcium-transporting ATPase 1
T3D0165 Hexachlorocyclopentadiene Gamma-aminobutyric acid receptor subunit theta
T3D0165 Hexachlorocyclopentadiene Gamma-aminobutyric acid receptor subunit rho-3
T3D0165 Hexachlorocyclopentadiene Gamma-aminobutyric acid receptor subunit rho-2
T3D0165 Hexachlorocyclopentadiene Gamma-aminobutyric acid receptor subunit rho-1
T3D0165 Hexachlorocyclopentadiene Gamma-aminobutyric acid receptor subunit pi
T3D0165 Hexachlorocyclopentadiene Gamma-aminobutyric acid receptor subunit gamma-3
T3D0165 Hexachlorocyclopentadiene Gamma-aminobutyric acid receptor subunit gamma-2
T3D0165 Hexachlorocyclopentadiene Gamma-aminobutyric acid receptor subunit gamma-1
T3D0165 Hexachlorocyclopentadiene Gamma-aminobutyric acid receptor subunit epsilon
T3D0165 Hexachlorocyclopentadiene Gamma-aminobutyric acid receptor subunit delta
T3D0165 Hexachlorocyclopentadiene Gamma-aminobutyric acid receptor subunit beta-3
T3D0165 Hexachlorocyclopentadiene Gamma-aminobutyric acid receptor subunit beta-2
T3D0165 Hexachlorocyclopentadiene Gamma-aminobutyric acid receptor subunit beta-1
T3D0165 Hexachlorocyclopentadiene Gamma-aminobutyric acid receptor subunit alpha-6
T3D0165 Hexachlorocyclopentadiene Gamma-aminobutyric acid receptor subunit alpha-5
T3D0165 Hexachlorocyclopentadiene Gamma-aminobutyric acid receptor subunit alpha-4
T3D0165 Hexachlorocyclopentadiene Gamma-aminobutyric acid receptor subunit alpha-3
T3D0165 Hexachlorocyclopentadiene Gamma-aminobutyric acid receptor subunit alpha-2
T3D0165 Hexachlorocyclopentadiene Gamma-aminobutyric acid receptor subunit alpha-1
T3D0165 Hexachlorocyclopentadiene Calcium-transporting ATPase type 2C member 2
T3D0165 Hexachlorocyclopentadiene Calcium-transporting ATPase type 2C member 1
T3D0165 Hexachlorocyclopentadiene Retinoic acid receptor RXR-alpha
T3D0165 Hexachlorocyclopentadiene Androgen receptor
T3D0165 Hexachlorocyclopentadiene Nuclear factor erythroid 2-related factor 2
T3D0165 Hexachlorocyclopentadiene Metal regulatory transcription factor 1
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3